跳至主要内容
临床试验/NCT03939338
NCT03939338Unknown不适用

Combination With Regulatory T Cell Levels and Cardiac Magnetic Resonance Imaging (CMR) to Assess the Severity and Prognosis of Reperfusion Injury After Primary PCI in STEMI Patients (TregCMRRS)

Beijing Friendship Hospital1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2019年7月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
250
试验地点
1
主要终点
MACE (major adverse cardiovascular events)

研究概览

简要总结

This study aims to determine whether combination with regulatory T cell (Treg) levels and cardiac magnetic resonance imaging (CMR) are predictive of the severity of reperfusion injury following myocardial infarction and the prognosis in STEMI patients receiving primary percutaneous coronary intervention (PPCI).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Confirmed STEMI diagnosis
  • Undergoing primary percutaneous coronary intervention (presenting <12 hours after symptom onset)
  • Patients were able to complete cardiac magnetic resonance imaging (CMR) and speckle tracking imaging echocardiogram (STE) examinations
  • Patients agreed and provided informed consent

排除标准

  • Previous myocardial infarction or revascularization (PCI or CABG)
  • Congestive heart failure with LVEF<40%
  • Atrial fibrillation
  • Renal insufficiency (GFR < 30 ml/min/1.73m^2)
  • Acute infectious diseases within nearly 3 months
  • Rheumatic immune system diseases
  • Malignant tumors
  • Claustrophobia
  • Contraindicated to CMR
  • Patients do not agree to be included in the study

结局指标

主要结局

MACE (major adverse cardiovascular events)

时间窗: 12 months

nonfatal or fatal myocardial infarction, revascularization, cardiac death, nonfatal or fatal stroke, all cause of death

次要结局

  • adverse cardiac remodeling(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hongwei Li, MD

Prof.

Beijing Friendship Hospital

研究点 (1)

Loading locations...

相似试验

已完成
不适用
Evaluation of regulatory T cell and disease activity after transdermal administration of Dovonex(r) ointment 50ug/g in patients with rheumatoid arthritisRheumatoid arthritis
JPRN-UMIN000022296Medical Co.LTA PS Clinic20
已完成
不适用
Maternal Plasmatic Regulatory T Cells and Th17 as Possible Diagnosis Markers of Acute ChorioamnionitisPathology of Pregnancy
NCT01610258Centre Hospitalier Universitaire Dijon95
招募中
不适用
Early Assessment of Cardiac Function After Treatment With CAR-T CellsCar T- CellHematologic MalignancyLymphoma, B-CellMultiple MyelomaAcute Lymphoblastic Leukemia
NCT06350994Assistance Publique - Hôpitaux de Paris60
已完成
不适用
RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-DHeart Failure
NCT00453622Abbott Medical Devices222
招募中
不适用
Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell TherapyRecurrent Aggressive B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell LymphomaRecurrent Primary Mediastinal (Thymic) Large B-Cell LymphomaRecurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaRefractory Aggressive B-Cell Non-Hodgkin LymphomaRefractory Diffuse Large B-Cell LymphomaRefractory High Grade B-Cell LymphomaRefractory Primary Mediastinal (Thymic) Large B-Cell LymphomaRefractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
NCT04870853M.D. Anderson Cancer Center150